Back
Sutro Biopharma Stock Price Chart

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
40
STRO
Sutro Biopharma
Last Price:
$0.87
Seasonality Move:
0.48%
7 Day Trial
ALL ACCESS PASS
$
7

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STRO is experiencing selling pressure, which indicates risk of future bearish movement.
Sutro Biopharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.01 | Sell |
20-day SMA: | 0.85 | Buy |
50-day SMA: | 0.91 | Sell |
200-day SMA: | 2.55 | Sell |
8-day EMA: | 0.95 | Sell |
20-day EMA: | 0.9 | Sell |
50-day EMA: | 1.03 | Sell |
200-day EMA: | 2.19 | Sell |
Sutro Biopharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 48.52 | Sell |
Chaikin Money Flow: | -965062 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.59 - 1.03) | Buy |
Bollinger Bands (100): | (0.85 - 1.97) | Sell |
Sutro Biopharma Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sutro Biopharma Stock
Is Sutro Biopharma Stock a Buy?
-
Sutro Biopharma share price is 0.87 while STRO 8-day simple moving average is 1.01, which is a Sell signal.
-
The stock price of STRO is 0.87 while Sutro Biopharma 20-day SMA is 0.85, which makes it a Buy.
-
Sutro Biopharma 50-day simple moving average is 0.91 while STRO share price is 0.87, making it a Sell technically.
-
STRO stock price is 0.87 and Sutro Biopharma 200-day simple moving average is 2.55, creating a Sell signal.
STRO Technical Analysis vs Fundamental Analysis
Sell
40
Sutro Biopharma (STRO)
is a Sell
Is Sutro Biopharma a Buy or a Sell?
-
Sutro Biopharma stock is rated a SellThe current Sutro Biopharma [STRO] share price is $0.87. The Score for STRO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Sutro Biopharma Stock Info
Market Cap:
73M
Price in USD:
0.87
Share Volume:
1.1M
Sutro Biopharma 52-Week Range
52-Week High:
5.17
52-Week Low:
0.52
Sell
40
Sutro Biopharma (STRO)
is a Sell
Sutro Biopharma Share Price Forecast
-
What is the Sutro Biopharma stock price today?The Sutro Biopharma stock price is 0.87 USD today.
-
Will STRO stock go up or go down?Sutro Biopharma> share price is forecast to RISE/FALL based on technical indicators
-
Is Sutro Biopharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sutro Biopharma is overvalued.
Is Sutro Biopharma Stock a Buy?
-
Sutro Biopharma share price is 0.87 while STRO 8-day exponential moving average is 0.95, which is a Sell signal.
-
The stock price of STRO is 0.87 while Sutro Biopharma 20-day EMA is 0.90, which makes it a Sell.
-
Sutro Biopharma 50-day exponential moving average is 1.03 while STRO share price is 0.87, making it a Sell technically.
-
STRO stock price is 0.87 and Sutro Biopharma 200-day simple moving average is 2.19, creating a Sell signal.
Fundamental Analysis of Sutro Biopharma
Is Sutro Biopharma a good investment?
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $2.05 per share.
Technical Analysis of Sutro Biopharma
Should I short Sutro Biopharma stock?
-
STRO Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Sutro Biopharma is a Buy
-
Sutro Biopharma Relative Strength Index (RSI) is 48.52, which suggest Sutro Biopharma is oversold
-
The Bollinger Bands (25) for Sutro Biopharma is (0.59 - 1.03), which suggest Sutro Biopharma is a Sell
-
The Bollinger Bands (100) for Sutro Biopharma is (0.85 - 1.97), which suggest Sutro Biopharma is a Sell
* Sutro Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.